2002 Minority International Research Training Grant, Fogarty International Center, NIH & Medical Research Council of South Africa, Cape Town, South Africa
2003 AIDS Minority Training Grant, Fogarty International Center, NIH & Programa de Computacao Cientifica, Fundacao Instituto Oswaldo Cruz, Rio de Janeiro, Brazil
2004 Minority International Research Training Grant, Fogarty International Center, NIH & The World Health Organization, Geneva, Switzerland
2004-2009 Predoctoral Training Grant in HIV/AIDS, Department of Biostatistics, Harvard University
2011 Partners in Excellence Award, Massachusetts General Hospital
1. Fay MP, Noubary F, Saul A. Robust Non-inferiority Tests for Potency of a Test Drug Against a Reference Drug. Statistics in biopharmaceutical research. 2009;1(3):291-300.
2. Noubary F, Hughes MD. Assessing agreement in the timing of treatment initiation determined by repeated measurements of novel versus gold standard technologies with application to the monitoring of CD4 counts in HIV-infected patients. Statistics in medicine. 2010;29(18):1932-46.
3. Andrews JR, Noubary F, Walensky RP, Cerda R, Losina E, Horsburgh CR. Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. Clinical infectious diseases. 2012;54(6):784-91.
4. Pollock NR, Rolland JP, Kumar S, Beattie PD, Jain S, Noubary F, et al. A paper-based multiplexed transaminase test for low-cost, point-of-care liver function testing. Science translational medicine. 2012;4(152):152ra29.
5. Noubary F, Hughes MD. Factors affecting timing of antiretroviral treatment initiation based on monitoring CD4 counts. Journal of acquired immune deficiency syndromes (1999). 2012;61(3):326-33.
6. Ahonkhai AA, Noubary F, Munro A, Stark R, Wilke M, Freedberg KA, et al. Not all are lost: interrupted laboratory monitoring, early death, and loss to follow-up (LTFU) in a large South African treatment program. PloS one. 2012;7(3):e32993.
7. Drain PK, Hyle EP, Noubary F, Freedberg KA, Wilson D, Bishai WR, et al. Diagnostic point-of-care tests in resource-limited settings. The Lancet infectious diseases. 2013.
8. Ramirez-Avila L, Noubary F, Pansegrouw D, Sithole S, Giddy J, Losina E, et al. The Acceptability and Feasibility of Routine Pediatric HIV Testing in an Outpatient Clinic in Durban, South Africa. The Pediatric infectious disease journal. 2013.
9. Walensky RP, Ross EL, Kumarasamy N, Wood R, Noubary F, Paltiel AD, et al. Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. The New England journal of medicine. 2013;369(18):1715-25.
10. Shenoy, E. S., Noubary, F., Kim, J., Rosenberg, E. S., Cotter, J. A., Lee, H., ... & Hooper, D. C. Concordance of PCR and culture from nasal swabs for MRSA in setting of concurrent anti-staphylococcal antibiotics. Journal of Clinical Microbiology. 2014 [Epub ahead of print].
Dr. Noubary’s research interests include statistical methods for the design and analysis of studies evaluating novel diagnostics, longitudinal data analysis, decision analysis, and clinical epidemiology, particularly in the context of HIV, TB, and other infectious diseases. He was previously a member of the “Cost-effectiveness of Preventing AIDS Complications (CEPAC)” group, an HIV modeling team at the Massachusetts General Hospital and has ongoing work with investigators developing novel CD4 enumeration and liver function monitoring technologies. He is also interested in innovative approaches to teaching biostatistics to clinical audiences and has experience developing a distance learning course. At Tufts, he is the primary instructor of the biostatistics curriculum in the Clinical and Translational Science Program at the Sackler School of Graduate Biomedical Sciences.
Email: Farzad Noubary
Biostatistics, Epidemiology, and Research Design (BERD) Center
Tufts Medical Center
35 Kneeland Street, 9th Floor
Boston, MA 02111